跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
human antithrombin III
首页
药物
human antithrombin III
human antithrombin III
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Treatments using transgenic goat produced antithrombin III
US 7019193 B2
申请人: GTC BIOTHERAPEUTICS INC
优先权: 2002
US
4 件公开
Pharmaceutical preparation for the treatment of inflammatory processes
US 6399572 B1
申请人: AVENTIS BEHRING GMBH
优先权: 1999
US
3 件公开
Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III
US 8563693 B2
申请人: GEIBEN-LYNN RALF
优先权: 2010
US
2 件公开
Method for separating and purifying human antithrombin-III (AT-III) from human plasma
CN 104672326 A
申请人: GUIZHOU TAIBANG BIOLOG PRODUCTS CO LTD
优先权: 2013
CN
2 件公开
Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof
US 6692931 B1
申请人: REUTTER WERNER
优先权: 1998
US
Porphyromonas gingivalis arginine-specific proteinase coding sequences
US 6274718 B1
申请人: UNIV GEORGIA RES FOUND
优先权: 2000
US
Capillary membrane stabilization and reduction of tissue injury through use of biodegradable macromolecules with antioxidants and/or other chemicals
US 2006264357 A1
申请人: ZIKRIA BASHIR A
优先权: 2005
US
Preparation method for human antithrombin III
CN 105315365 A
申请人: SHANGHAI ZHOUYUE BIOTECHNOLOGY CO LTD
优先权: 2015
CN
Method for producing antithrombin III by using plasma waste component IV precipitate
CN 121591877 A
申请人: CHINA RESOURCES BOYA BIO PHARMACEUTICAL GROUP CO LTD
优先权: 2025
CN
药物
反馈